Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Research & Studies
Share your love
What Is Staphyloma? | OBN
Staphyloma is a bulging or protrusion of the eye’s inner layers through a thinned area of the outer layers. It is typically caused by a structural weakness in the eye, and it can lead to vision problems if left untreated.…
The 40th Congress of the ESCRS | Milan 16
The 40th Congress of the ESCRS is taking place from 16-20 September 2022, at the Milano Convention Centre in Milan, Italy. The congress, which will host around 1,000 registered participants, will also be streamed via the virtual conferencing platform now…
Novartis’ AMD Drug Linked to Rare Retinal Side Effects
Two recent studies have found that a drug called brolucizumab, which was approved in 2019 and developed by Swiss pharmaceutical company Novartis AG to treat wet age-related macular degeneration (AMD), can cause rare retinal side effects due to its interaction…
Use of Telemedicine in Ophthalmology
The medical industry is undergoing radical change as we enter the digital age. One such change is the advent of telemedicine – a powerful tool enabling healthcare providers to connect with patients remotely. Ophthalmology, the branch of medicine dedicated to…
What is Ophthalmology? | OBN
The word itself originates from Greek words phthalmos, “eye” and -logia, “study” and Ophthalmology means “the study of eyes”. Ophthalmology is the branch in medicine that concerns the medical conditions and health of the eyes. The discipline covers all animal…
DORC Receives FDA Clearance for Eva Nexus System
DORC International has announced 510(k) market clearance and the launch of the Eva Nexus. According to DORC, the Eva Nexus features multiple innovations to improve performance, efficiency, and stability for retina surgeons, including Smart IOP for anterior and posterior chamber stability; DORC’s trocar cannula system with HI-FLOW infusion…
Primary Open Angle Glaucoma (POAG)
A subtype of glaucomas known as primary open angle glaucoma (POAG) is characterized by an open, seemingly normal anterior chamber angle and elevated intraocular pressure (IOP), with no additional underlying disease. Secondary glaucoma is a condition where the elevated IOP…
What is Photophobia and How to Manage it
Photophobia, or sensitivity to light, is a common condition characterized by discomfort or pain in response to exposure to light. While it can occur in individuals with healthy eyes, photophobia is often associated with underlying eye conditions or systemic diseases.…
Harrow Starts Triesence Relaunch Strategy
Harrow Pharmaceuticals announced its efforts to relaunch Triesence (triamcinolone acetonide injectable suspension) 40 mg/mL in the United States market. The company announced the successful manufacture of the first of three commercial-scale Process Performance Qualification (PPQ) batches required for the relaunch.…
Opus Secures $1.7M Funding from Foundation Fighting Blindness
Opus Genetics, a pioneering gene therapy company focused on inherited retinal diseases, has secured $1.7 million in project-based funding from the Foundation Fighting Blindness. This financial support aims to accelerate the development of two preclinical candidate programs critical for advancing…